Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prothena Corp Public (PRTA) Return on Sales (2016 - 2025)

Prothena Corp Public (PRTA) has 14 years of Return on Sales data on record, last reported at 1029.19% in Q4 2025.

  • For Q4 2025, Return on Sales fell 100189.0% year-over-year to 1029.19%; the TTM value through Dec 2025 reached 25.21%, down 2430.0%, while the annual FY2025 figure was 25.21%, 2430.0% down from the prior year.
  • Return on Sales reached 1029.19% in Q4 2025 per PRTA's latest filing, down from 15.13% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.78% in Q3 2021 and bottomed at 1444.78% in Q1 2024.
  • Average Return on Sales over 5 years is 161.24%, with a median of 27.79% recorded in 2021.
  • Peak YoY movement for Return on Sales: tumbled -142317bps in 2024, then soared 142349bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 28.28% in 2021, then skyrocketed by 100bps to 0.13% in 2022, then tumbled by -167978bps to 213.5% in 2023, then skyrocketed by 87bps to 27.3% in 2024, then tumbled by -3670bps to 1029.19% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 1029.19% in Q4 2025, 15.13% in Q3 2025, and 28.45% in Q2 2025.